Franklin New Financials

FKNIX Fund  USD 10.70  0.02  0.19%   
You can utilize Franklin New York fundamental data analysis to find out if markets are presently mispricing the fund. We were able to collect and analyze data for thirteen available fundamental indicators for Franklin New York, which can be compared to its peers. The fund experiences a normal upward fluctuation. Check odds of Franklin New to be traded at $11.24 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Franklin New Fund Summary

Franklin New competes with Franklin Natural, Jennison Natural, Invesco Energy, Short Oil, and Thrivent Natural. Under normal market conditions, the fund invests at least 80 percent of its total assets in securities whose interest is free from federal income taxes, including the federal alternative minimum tax, and from New York State personal income taxes. Although the fund tries to invest all of its assets in tax-free securities, it is possible that up to 20 percent of the funds total assets may be invested in securities that pay interest subject to federal or state income taxes.
Specialization
Muni New York Intermediate, Large
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
ISINUS3541283087
Business AddressFranklin New York
Mutual Fund FamilyFranklin Templeton Investments
Mutual Fund CategoryMuni New York Intermediate
BenchmarkDow Jones Industrial
Phone800 342 5236
CurrencyUSD - US Dollar

Franklin New Key Financial Ratios

Franklin Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Franklin New's current stock value. Our valuation model uses many indicators to compare Franklin New value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Franklin New competition to find correlations between indicators driving Franklin New's intrinsic value. More Info.
Franklin New York is rated # 2 fund in annual yield among similar funds. It is one of the top funds in year to date return among similar funds creating about  179.41  of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Franklin New's earnings, one of the primary drivers of an investment's value.

Franklin New York Systematic Risk

Franklin New's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Franklin New volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Franklin New York correlated with the market. If Beta is less than 0 Franklin New generally moves in the opposite direction as compared to the market. If Franklin New Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Franklin New York is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Franklin New is generally in the same direction as the market. If Beta > 1 Franklin New moves generally in the same direction as, but more than the movement of the benchmark.
Franklin New York is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Muni New York Intermediate category is currently estimated at about 2.27 Billion. Franklin New totals roughly 608.06 Million in net asset claiming about 27% of funds under Muni New York Intermediate category.

Franklin New December 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Franklin New help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Franklin New York. We use our internally-developed statistical techniques to arrive at the intrinsic value of Franklin New York based on widely used predictive technical indicators. In general, we focus on analyzing Franklin Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Franklin New's daily price indicators and compare them against related drivers.

Other Information on Investing in Franklin Mutual Fund

Franklin New financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin New security.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments